Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-6124 long-term extension study in schizophrenia
2012-003228-19Phase 3Terminated
- Sponsor
- FORUM Pharmaceuticals
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of encenicline in schizophrenia, sponsored by FORUM Pharmaceuticals. Started Jan 2014; status: terminated.
02
Drugs
encenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-003228-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003228-19.